Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 325 of 1467 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 04/17/08
End: 02/28/10
Due: 02/28/11
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 08/31/07
Due: 08/31/08
Phase: N/A
Priority: Normal
Start: 02/27/17
End: 05/12/17
Due: 05/12/18
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 09/30/09
Due: 09/30/10
Phase: N/A
Priority: Normal
Start: 05/15/15
End: 05/26/21
Due: 05/26/22
Phase: N/A
Priority: Normal
Start: 02/06/20
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 07/31/05
Due: 07/31/06
Phase: N/A
Priority: Normal
Start: 09/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 08/31/07
Due: 08/31/08
Phase: N/A
Priority: Normal
Start: 09/30/03
End: 06/30/04
Due: 06/30/05
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 08/31/09
Due: 08/31/10
Phase: N/A
Priority: Normal
Start: 06/30/05
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 07/31/07
Due: 07/31/08
Phase: N/A
Priority: Normal
Start: 05/31/05
End: 02/28/06
Due: 02/28/07
Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma
Phase: N/A
Priority: Normal
Start: 10/31/04
End: 03/31/08
Due: 03/31/09
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 02/17/22
End: 01/11/23
Due: 01/11/24
Phase: N/A
Priority: Normal
Start: 07/31/07
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 08/24/16
End: 08/06/18
Due: 08/06/19
Phase: N/A
Priority: Normal
Start: 04/30/06
End: 07/31/08
Due: 07/31/09
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 04/30/12
Due: 04/30/13
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 08/31/06
Due: 08/31/07